Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Emotion perception refers to a set of neurocognitive processes by which individuals recognize, interpret, and respond to emotional stimuli in the environment. It involves multiple distributed neural systems, including the amygdala, insula, striatum, anterior cingulate gyrus, and prefrontal cortex, which are activated during identification of emotionally salient information, generation of affective states, and regulation of those states[1][3][5][7]. Genetic factors may influence the ability to perceive emotions, particularly in facial emotion recognition, with significant involvement of the amygdala[2][4]. Abnormalities in emotion perception are associated with psychiatric disorders such as schizophrenia, bipolar disorder, and major depressive disorder[3]. While no drugs directly target "emotion perception," pharmacological interventions that affect neurotransmitter systems can influence emotional processing[4]. This process is critical for social functioning, emotional communication, and adaptive behavior.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Emotion perception.